For the quarter ending 2026-03-31, IDXG has $33,409K in assets. $10,327K in debts. $2,647K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,647 | 2,505 | 1,423 | 502 |
| Accounts receivable | 5,925 | 5,649 | 5,966 | 7,231 |
| Other current assets | 1,391 | 1,746 | 1,741 | 1,771 |
| Total current assets | 9,963 | 9,900 | 9,130 | 9,504 |
| Property and equipment, net | 1,315 | 1,423 | 1,541 | 1,366 |
| Operating lease right of use assets | 1,110 | 1,217 | 1,320 | 1,420 |
| Deferred tax asset | 20,977 | 21,254 | - | - |
| Other long-term assets | 44 | 44 | 45 | 45 |
| Total assets | 33,409 | 33,838 | 12,036 | 12,335 |
| Accounts payable | 805 | 983 | 1,411 | 1,250 |
| Accrued salary and bonus | 714 | 1,886 | 1,447 | 2,045 |
| Other accrued expenses | 1,783 | 1,574 | 1,450 | 1,422 |
| Note payable at fair value | - | - | 977 | 1,772 |
| Current liabilities of discontinued operations | 660 | 660 | 660 | 660 |
| Total current liabilities | 3,962 | 5,103 | 5,945 | 7,149 |
| Operating lease liabilities, net of current portion | 635 | 752 | 864 | 974 |
| Other long-term liabilities | 5,730 | 5,620 | 5,525 | 5,425 |
| Redeemable preferred stock, .01 par value 5,000,000 shares authorized, 47,000 shares series c issued and outstanding | - | - | - | 0 |
| Total liabilities | 10,327 | 11,475 | 12,334 | 13,548 |
| Common stock, .01 par value 100,000,000 shares authorized 27,844,994 and 4,569,333 shares issued, respectively 27,700,904 and 4,428,539 shares outstanding, respectively | 640 | 407 | 407 | 407 |
| Additional paid-in capital | 234,604 | 234,833 | 234,829 | 234,822 |
| Accumulated deficit | -210,084 | -210,805 | -233,462 | -234,373 |
| Treasury stock, at cost (144,090 and 140,794 shares, respectively) | 2,078 | 2,072 | 2,072 | 2,069 |
| Total stockholders equity | 23,082 | 22,363 | -298 | -1,213 |
| Total liabilities and stockholders equity | 33,409 | 33,838 | 12,036 | 12,335 |
INTERPACE BIOSCIENCES, INC. (IDXG)
INTERPACE BIOSCIENCES, INC. (IDXG)